EC Probes India’s GVK Bio For Data Integrity Spanning Six Years
This article was originally published in The Pink Sheet Daily
Executive Summary
The Indian drug industry has seen close regulatory scrutiny on GMP and data integrity issues. Now GVK Bio, a large-sized CRO, is being investigated by European agencies for alleged data integrity issues in clinical research stretching across a six-year period.